indazoles has been researched along with navitoclax in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belmont, LD; Fairbrother, WJ; Hong, R; Lee, LB; Nannini, MA; Price, S; Sampath, D; Savy, PP; Settleman, J; Tan, N; Williams, K; Wong, M; Yue, P | 1 |
| Canoll, PD; Crary, JF; Macleod, D; Pareja, F; Ross, AH; Shu, C; Siegelin, MD | 1 |
| Chinen, Y; Horiike, S; Kobayashi, T; Kuroda, J; Kuwahara-Ota, S; Maegawa, S; Matsumura-Kimoto, Y; Mizuno, Y; Shimura, Y; Takimoto, T; Tanba, K; Taniwaki, M; Tsukamoto, T | 1 |
3 other study(ies) available for indazoles and navitoclax
| Article | Year |
|---|---|
Bcl-2/Bcl-xL inhibition increases the efficacy of MEK inhibition alone and in combination with PI3 kinase inhibition in lung and pancreatic tumor models.
Topics: Aniline Compounds; Apoptosis; bcl-X Protein; Cell Line, Tumor; Enzyme Inhibitors; Genes, bcl-2; Humans; Indazoles; Lung Neoplasms; MAP Kinase Kinase Kinases; Molecular Targeted Therapy; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Signal Transduction; Sulfonamides | 2013 |
PI3K and Bcl-2 inhibition primes glioblastoma cells to apoptosis through downregulation of Mcl-1 and Phospho-BAD.
Topics: Aniline Compounds; Apoptosis; bcl-Associated Death Protein; Cell Line, Tumor; Down-Regulation; Glioblastoma; Humans; Indazoles; Myeloid Cell Leukemia Sequence 1 Protein; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Sulfonamides; Transfection | 2014 |
Phosphoinositide-dependent protein kinase 1 is a potential novel therapeutic target in mantle cell lymphoma.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Aniline Compounds; Cell Line, Tumor; Humans; Indazoles; Lymphoma, Mantle-Cell; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrimidines; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Sulfonamides | 2018 |